Serina Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 73.3% | -633.2% | -275.0% |
| FY2022 | 60.8% | -1,147.1% | -322.8% |
| FY2023 | -16.3% | -16.3% | 58.8% |
| FY2024 | -1,738.1% | -1,738.1% | -165.7% |
| FY2025 | 51,843.2% | 51,843.2% | -276.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 73.3% | -633.2% | -275.0% |
| FY2022 | 60.8% | -1,147.1% | -322.8% |
| FY2023 | -16.3% | -16.3% | 58.8% |
| FY2024 | -1,738.1% | -1,738.1% | -165.7% |
| FY2025 | 51,843.2% | 51,843.2% | -276.0% |